deltatrials
Terminated NA INTERVENTIONAL 1-arm NCT00070317

Lymph Node Mapping and Sentinel Lymph Node Identification in Patients With Stage IB1 Cervical Cancer

Lymphatic Mapping and Sentinel Node Identification in Patients With Stage1B1 Cervical Carcinoma

Sponsor: Gynecologic Oncology Group

Conditions Cervical Adenocarcinoma Cervical Adenosquamous Carcinoma Cervical Squamous Cell Carcinoma Stage I Cervical Cancer
Interventions Isosulfan Blue Lymph Node Mapping Lymphangiography Methylene Blue Radionuclide Imaging Sentinel Lymph Node Biopsy Technetium Tc-99m Sulfur Colloid Therapeutic Conventional Surgery
Updated 8 times since 2017 Last updated: Oct 3, 2017 Started: Jun 30, 2004 Primary completion: Jan 31, 2013 Completion: Jan 31, 2013
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

This trial was terminated. No reason was provided.

Other terminated trials from Gynecologic Oncology Group

More terminations from Gynecologic Oncology Group

Other Cervical Adenocarcinoma trials with similar outcome

Browse all Cervical Adenocarcinoma trials

This NA trial investigates Cervical Adenocarcinoma and Cervical Adenosquamous Carcinoma and is currently terminated or withdrawn. Gynecologic Oncology Group leads this study, which shows 8 recorded versions since 2004 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotTerminated~Feb 2017 – ~Oct 2017 · 8 months · monthly snapshotTerminated~Oct 2017 – ~Jun 2018 · 8 months · monthly snapshotTerminated~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotTerminated~Jan 2021 – ~Feb 2021 · 31 days · monthly snapshotTerminated~Feb 2021 – ~Jul 2024 · 41 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotTerminated~Sep 2024 – present · 21 months · monthly snapshotTerminated

Change History

8 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated NA

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated NA

  3. Feb 2021 — Jul 2024 [monthly]

    Terminated NA

  4. Jan 2021 — Feb 2021 [monthly]

    Terminated NA

  5. Jun 2018 — Jan 2021 [monthly]

    Terminated NA

▶ Show 3 earlier versions

  1. Oct 2017 — Jun 2018 [monthly]

    Terminated NA

  2. Feb 2017 — Oct 2017 [monthly]

    Terminated NA

  3. Jan 2017 — Feb 2017 [monthly]

    Terminated NA

    First recorded

Jun 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Gynecologic Oncology Group
  • National Cancer Institute (NCI)
Data source: GOG Foundation

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations